# Velan Capital Investment Management LP — merger/spac_merger [announced]
Source: SEC API (secapi.ai) · situation sit_2ecd58f9f0fbcd8bc524 · retrieved 2026-08-11T15:49:14.632Z

## Overview
On July 16, 2026, Jasper Therapeutics, Inc. acquired Kira Pharmaceuticals, a Cayman Islands exempted company, pursuant to an Agreement and Plan of Merger dated July 16, 2026. Kira merged with and into Kira Holdco Inc., a Delaware corporation and wholly owned subsidiary of Jasper, with Kira Holdco continuing as the surviving corporation and a wholly owned subsidiary of Jasper. The merger resulted in the issuance of 5,195,009 shares to Kira shareholders pursuant to the Merger Agreement.

## Terms
- Counterparty: Kira Pharmaceuticals · Consideration: stock

## Key dates
- Announced 2026-07-20

## Timeline
- 2026-07-20 · SCHEDULE 13D/A (0000921895-26-001834): SCHEDULE 13D/A - Velan Capital Investment Management LP — On July 16, 2026, Jasper Therapeutics, Inc. acquired Kira Pharmaceuticals, a Cayman Islands exempted company, pursuant to an Agreement and Plan of Merger dated July 16, 2026. Kira merged with and into Kira Holdco Inc., a Delaware corporation and wholly owned subsidiary of Jasper, with Kira Holdco continuing as the surviving corporation and a wholly owned subsidiary of Jasper. The merger resulted in the issuance of 5,195,009 shares to Kira shareholders pursuant to the Merger Agreement.
  https://www.sec.gov/Archives/edgar/data/1848809/0000921895-26-001834.txt

## Citations
- 0000921895-26-001834 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000092189526001834